These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. T-cell response to purified protein derivative after removal of Langerhans' cells from epidermal cell suspensions containing keratinocytes expressing class II transplantation antigens. Tjernlund U, Scheynius A, Johansson C, Hagforsen E, Nilsson H. Scand J Immunol; 1988 Dec; 28(6):667-73. PubMed ID: 3266023 [Abstract] [Full Text] [Related]
3. Amplification of T-cell response to PPD by epidermal cell suspensions containing HLA-DR-expressing keratinocytes. Tjernlund U, Scheynius A. Scand J Immunol; 1987 Jul; 26(1):1-6. PubMed ID: 2441455 [Abstract] [Full Text] [Related]
4. Retinoic acid upregulates human Langerhans cell antigen presentation and surface expression of HLA-DR and CD11c, a beta 2 integrin critically involved in T-cell activation. Meunier L, Bohjanen K, Voorhees JJ, Cooper KD. J Invest Dermatol; 1994 Dec; 103(6):775-9. PubMed ID: 7798614 [Abstract] [Full Text] [Related]
5. Cutaneous T-cell lymphoma lesional epidermal cells activate autologous CD4+ T lymphocytes: involvement of both CD1+OKM5+ and CD1+OKM5- antigen-presenting cells. Hansen ER, Baadsgaard O, Lisby S, Cooper KD, Thomsen K, Vejlsgaard GL. J Invest Dermatol; 1990 Apr; 94(4):485-91. PubMed ID: 1968933 [Abstract] [Full Text] [Related]
6. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8. Berg L, Rönnelid J, Sanjeevi CB, Lampa J, Klareskog L. Arthritis Res; 2000 Apr; 2(1):75-84. PubMed ID: 11219392 [Abstract] [Full Text] [Related]
7. Human keratinocytes express HLA-DR antigens in the tuberculin reaction. Scheynius A, Tjernlund U. Scand J Immunol; 1984 Feb; 19(2):141-7. PubMed ID: 6367023 [Abstract] [Full Text] [Related]
8. HLA-D/DR restriction of macrophage-dependent antigen activation of immune T lymphocytes: cross-reacting allogeneic HLA-D/DR may partly substitute for self HLA-D/DR. Bergholtz BO, Thoresen AB, Thorsby E. Scand J Immunol; 1980 Feb; 11(5):541-8. PubMed ID: 6155693 [Abstract] [Full Text] [Related]
9. Cellular and humoral immunity to purified protein derivative (PPD) in PPD skin reactive and nonreactive patients with pulmonary tuberculosis: comparative analysis of antigen-specific lymphocyte proliferation and IgG antibodies. Boras Z, Juretić A, Rudolf M, Uzarević B, Trescec A. Croat Med J; 2002 Jun; 43(3):301-5. PubMed ID: 12035136 [Abstract] [Full Text] [Related]
10. Class II transplantation antigens in the late human skin tuberculin reaction. Scheynius A, Tjernlund U. Scand J Immunol; 1985 Aug; 22(2):227-33. PubMed ID: 2412281 [Abstract] [Full Text] [Related]
11. Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumor necrosis factor. Griffiths CE, Voorhees JJ, Nickoloff BJ. J Am Acad Dermatol; 1989 Apr; 20(4):617-29. PubMed ID: 2497153 [Abstract] [Full Text] [Related]
12. Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques. Gottlieb AB, Lifshitz B, Fu SM, Staiano-Coico L, Wang CY, Carter DM. J Exp Med; 1986 Oct 01; 164(4):1013-28. PubMed ID: 2428913 [Abstract] [Full Text] [Related]
19. In situ identification of T lymphocyte subsets and HLA-DR expressing cells in the human skin tuberculin reaction. Scheynius A, Klareskog L, Forsum U. Clin Exp Immunol; 1982 Aug 01; 49(2):325-30. PubMed ID: 6751638 [Abstract] [Full Text] [Related]